In the US, Mesna (mesna systemic) is a member of the drug class antineoplastic detoxifying agents and is used to treat Hemorrhagic Cystitis Prophylaxis.
US matches:
- Mesna
- Mesna Tablets
- Mesna Intravenous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
R05CB05,V03AF01
CAS registry number (Chemical Abstracts Service)
0019767-45-4
Chemical Formula
C2-H5-Na-O3-S2
Molecular Weight
164
Therapeutic Category
Mucolytic agent
Chemical Name
Ethanesulfonic acid, 2-mercapto-, monosodium salt
Foreign Names
- Mesnum (Latin)
- Mesna (German)
- Mesna (French)
- Mesna (Spanish)
Generic Names
- Mesna (OS: USAN, DCIT, DCF, BAN)
- Asta D 7093 (IS: Asta)
- Sodium 2-mercaptoethanesulfonate (IS: WHO)
- UCB 3983 (IS: UCB)
- Mesna (PH: BP 2010, Ph. Eur. 6)
- Mesnum (PH: Ph. Eur. 6)
Brand Names
- Anti-Uron
Pliva, Poland - Dabur Mesna
Dabur, Myanmar - Delinar
Teva, Argentina - Ifex / Mesnex Kit (Mesna and Ifosfamide)
Bristol-Myers Squibb, United States - Ifosfamide / Mesna Kit (Mesna and Ifosfamide)
Teva USA, United States - Mescryo
Cryopharma, Mexico - Mesna Biocrom
Biocrom, Argentina - Mesna Delta
Delta Farma, Argentina - Mesna Filaxis
Filaxis, Argentina - Mesna GP Pharm
GP Pharm, Peru - Mesna Microsules
Microsules, Argentina - Mesna Richmond
Richmond, Argentina; Richmond, Peru - Mesna Rontag
Rontag, Argentina - Mesna
APP, United States; Bedford, United States; Pharmaceutical Partners of Canada, Canada; Tecnofarma, Chile; Teva USA, United States - Mesna-cell
Cell pharm, Germany - Mesnex
Baxter, United States; Bristol-Myers Squibb, United States - Mesnil
Asofarma, Mexico - Mestian
LKM, Argentina - Mexan
Teva, Israel - Mistabron
GlaxoSmithKline, Poland; Pliva, Poland; UCB, Belgium; UCB, Czech Republic; UCB, Luxembourg; UCB, Netherlands; UCB, Philippines; UCB, Singapore; UCB, Taiwan; UCB, South Africa - Mucofluid
Sanofi-Pasteur, Chile; UCB, Spain; UCB, France; UCB, Poland - Neper
Ivax, Argentina; Ivax, Peru - Novacarel
Schein, Peru - Uromes
Korea United Pharm, Georgia - Uromitan
Eczacibasi Baxter, Turkey - Uromitexan
ASTA Medica, Cyprus; ASTA Medica, Ireland; ASTA Medica, Libya; ASTA Medica, Sudan; Aventis, South Africa; Baxter, United Arab Emirates; Baxter, Austria; Baxter, Australia; Baxter, Belgium; Baxter, Bahrain; Baxter, Canada; Baxter, Switzerland; Baxter, Chile; Baxter, Denmark; Baxter, Estonia; Baxter, Egypt; Baxter, Spain; Baxter, Finland; Baxter, France; Baxter, Greece; Baxter, Hong Kong; Baxter, Hungary; Baxter, Iraq; Baxter, Iran; Baxter, Iceland; Baxter, Jordan; Baxter, Kuwait; Baxter, Lebanon; Baxter, Lithuania; Baxter, Luxembourg; Baxter, Latvia; Baxter, Malta; Baxter, Netherlands; Baxter, Norway; Baxter, New Zealand; Baxter, Portugal; Baxter, Qatar; Baxter, Romania; Baxter, Saudi Arabia; Baxter, Sweden; Baxter, Syria; Baxter, Tunisia; Baxter, Vietnam; Baxter, Yemen; Baxter Oncology, Germany; Baxter Oncology, United Kingdom; Baxter Oncology, Oman; Baxter Oncology, Poland; Baxter Oncology, Singapore; Baxter Oncology-D, Italy; German Remedies, India; Sanofi-Aventis, Bangladesh; Shionogi Seiyaku, Japan; Temmler, Czech Republic; Temmler Pharma, Romania; Transfarma Medica Indah, Indonesia - Uroprot
Chile, Chile - Varimesna
Varifarma, Argentina
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment